• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Egg Allergy Market Trends

    ID: MRFR/Pharma/3312-CR
    85 Pages
    Rahul Gotadki
    June 2024

    Egg Allergy Market Research Report Information by Age Group (Children and Adults), Diagnosis & Treatment (Diagnosis [Skin Test, Blood Test, Food Challenge and others] and Treatment [Medication and Oral Immunotherapy]), End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes and others) - Forecast till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Egg Allergy Market Infographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Trends

    Key Emerging Trends in the Egg Allergy Market

    The egg allergy market is witnessing notable trends influenced by various factors such as increasing awareness, advancements in diagnostic technologies, and evolving treatment approaches. Egg allergy is one of the most common food allergies, particularly in children, characterized by adverse immune reactions to proteins found in eggs. One significant trend in this market is the growing recognition of egg allergy as a significant health concern, leading to heightened awareness among healthcare professionals, caregivers, and patients. As the prevalence of food allergies, including egg allergy, continues to rise, there is a growing demand for effective diagnostic tools and management strategies to improve outcomes and quality of life for individuals affected by this condition.

    Technological advancements play a pivotal role in shaping market trends in the egg allergy market. Innovations in diagnostic testing methods, such as skin prick tests, blood tests, and oral food challenges, enable more accurate and reliable identification of egg allergy in patients. Moreover, the development of molecular diagnostic tests and allergen-specific immunoglobulin E (IgE) assays allows for precise identification of specific egg proteins responsible for allergic reactions, facilitating targeted diagnostic and treatment approaches. Additionally, advancements in allergen component testing help differentiate between sensitization and clinical allergy to specific egg proteins, guiding personalized management strategies for patients with egg allergy.

    Furthermore, the increasing prevalence of egg allergy drives market growth for egg-free and allergen-reduced food products. With growing awareness of food allergies and dietary restrictions, there is a rising demand for safe and convenient food options for individuals with egg allergy. Food manufacturers are responding to this demand by developing a wide range of egg-free and allergen-friendly products, including baked goods, snacks, and convenience foods. Moreover, labeling regulations and certification programs for allergen-free products provide consumers with greater transparency and assurance regarding the safety and suitability of food products for individuals with egg allergy, further driving market expansion.

    Moreover, demographic shifts and changing consumer preferences influence market trends in the egg allergy market. With increasing urbanization, globalization, and multiculturalism, there is greater diversity in dietary habits and food choices, leading to heightened awareness of food allergies and intolerances. Additionally, changing lifestyle factors such as increased consumption of processed foods, dining out, and food allergies, including egg allergy, emphasize the importance of accurate labeling, allergen awareness, and food safety in foodservice establishments and food manufacturing facilities. Furthermore, the COVID-19 pandemic has underscored the importance of food safety and allergen management in food supply chains, prompting greater vigilance and adherence to regulatory standards and guidelines.

    Regulatory factors also play a significant role in shaping market trends in the egg allergy market. Regulatory agencies such as the FDA (Food and Drug Administration) and the European Food Safety Authority (EFSA) regulate the labeling, manufacturing, and marketing of food products, including allergen-free and hypoallergenic foods. Compliance with regulatory standards and guidelines, such as allergen labeling requirements and precautionary allergen labeling (PAL), is essential for market entry and consumer trust, ensuring product safety and transparency for individuals with food allergies, including egg allergy. Moreover, government initiatives and public health campaigns aimed at raising awareness of food allergies and promoting allergen management practices contribute to market growth and consumer education in the egg allergy market.

    Market Summary

    The Global Egg Allergy Market is projected to grow from 1.48 USD Billion in 2024 to 2.81 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Global Egg Allergy Key Trends and Highlights

    • The market is expected to expand at a compound annual growth rate (CAGR) of 6.0 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 2.81 USD Billion, indicating a substantial increase from the base year.
    • In 2024, the market is valued at 1.48 USD Billion, laying a strong foundation for future growth.
    • Growing adoption of allergen-free food products due to rising awareness of food allergies is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.48 (USD Billion)
    2035 Market Size 2.81 (USD Billion)
    CAGR (2025-2035) 6.0%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Genentech, Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo, Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Market Trends

    Major drivers of the market

    The egg allergy market size is evolving at a faster pace, and in the upcoming times, it will grow immensely. The number of cases of egg allergies is increasing day by day, both in adults as well as infants. Most number of cases over the years has happened to children more than egg allergy in adults. Symptoms of egg allergy in children outgrow way before it results in egg allergy symptoms in adults. The food allergy prevalence has increased to a greater extent which acts as a driving force for the growth of the global egg allergy market.

    Several technological advancements in egg allergy medication and treatment resulted in propelling the egg allergy market size. 

    The technological advancements in egg allergy treatment and diagnosis methods include skin prick test, food challenge, blood test, oral immunotherapy, and many more. These advanced methods of treatment increase the skin allergy test market size and help to propagate the growth of the egg allergy market to the optimum level in the forecast period.

    Significant growth opportunities for the market

    The egg allergy market is increasing to greater heights in a short time span, and the market will continue to grow in the future due to an extreme increase in egg allergy cases. The skin allergy test market size is rising exponentially with the advanced technological methods of diagnosis and treatment. These advancements are not just limited to egg allergy treatment but also include advancements in the identification process and screening. Various food scanners, apps, portable devices, and wearable are helpful in determining different food ingredients related to egg allergy.

    These devices are major opportunities for increasing the egg allergy industry size in the upcoming years.

    Market restraints

    The global egg allergy market is definitely growing at a faster rate, but the market growth can be hindered due to a lack of awareness among patients. The developing countries tend to avoid allergies, and the reason behind it lacks awareness. Many patients overlook the allergies and do not take any egg allergy treatment on time. The egg allergy cases in these countries are comparatively low, and the poor healthcare sector is also responsible for the same. Another prime restraint for the egg allergy industry is the hefty cost involved in the diagnosis and treatment process.

    Many tests are also not covered by any insurance policies. Such constraints restrict the growth of the egg allergy market size.

    Market Growth Challenges

    The egg allergy market is immensely dependent on the number of cases of egg allergy patients. Many patients overlook and avoid egg allergy medication in time which leads to declining market growth. Various tests like radioallergosorbent test (RAST) and enzyme-linked immunosorbent assay (ELISA or EIA) has their own limitations, which sometimes show false results and diagnosis failure due to cross-contamination. These testing procedures also require proficient egg allergy industry therapeutics who can handle the tests properly, which hinders the market growth of the egg allergy market size.

    Value Chain Analysis

    The revenue of the egg allergy industry is continuously escalating over the years and will continue to grow in the forecast years. Various egg research and consultancy sectors are focusing on the prevention and cure of the disease. The continuous effort for producing better egg allergy medication has resulted in the increasing the market value of the egg allergy market. The expansion of skin allergy test market size will reach greater levels in the upcoming years.

    The prevalence of egg allergy among children appears to be on the rise, necessitating increased awareness and management strategies to address this growing public health concern.

    Centers for Disease Control and Prevention (CDC)

    Egg Allergy Market Market Drivers

    Rising Prevalence of Egg Allergy

    The increasing incidence of egg allergy, particularly among children, is a primary driver of the Global Global Egg Allergy Market Industry. Studies indicate that egg allergy affects approximately 1.5 to 2.5 percent of children globally, with many outgrowing it by adolescence. However, the persistent cases contribute to a growing demand for allergen-free products. As awareness of food allergies rises, parents and caregivers are more vigilant, leading to increased consumption of egg-free alternatives. This trend is expected to propel the market, with projections estimating the market value to reach 1.48 USD Billion in 2024.

    Market Segment Insights

    Egg Allergy Age Group Insights

    The egg allergy industry size segmentation on the basis of age group includes children and adults. The egg allergy symptoms in adults are very less compared to children, so the children have the largest share in the egg allergy industry. 

    Egg Allergy Treatment Insights

    The treatment segment consists of sub-segments that include egg allergy medication and oral immunotherapy process, whereas the diagnosis segment consists of tests like blood tests, skin tests, and others.

    Egg Allergy end-user Insights

    Egg allergy market segmentation on the basis of end-user comprises hospitals and clinics, egg research and consultancy, and diagnostics centers. 

    Get more detailed insights about Egg Allergy Market by Share, Size, Growth and Overview – 2030

    Regional Insights

    Key Companies in the Egg Allergy Market market include

    Industry Developments

    Future Outlook

    Egg Allergy Market Future Outlook

    The Global Egg Allergy Market is projected to grow at a 6.0% CAGR from 2024 to 2035, driven by rising awareness, innovative treatments, and increasing prevalence of allergies.

    New opportunities lie in:

    • Develop personalized dietary solutions for egg allergy patients.
    • Invest in research for novel immunotherapy treatments.
    • Expand product lines to include egg-free alternatives in mainstream markets.

    By 2035, the market is expected to demonstrate robust growth, reflecting heightened consumer demand and innovative solutions.

    Market Segmentation

    Report Scope

    Attribute/Metric Details
    Market Size USD 2.01643 Billion by 2030
    CAGR 6.90% (2022-2030)
    Base Year   2021
    Forecast Period   2022-2030
    Historical Data   2020
    Forecast Units   Value (USD Billion)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Segments Covered Types, end user, Region
    Geographies Covered America, Europe, Asia Pacific, Middle East and Africa
    Key Vendors Genentech Inc. (the US), Sanofi SA (France), ImmuneTech (US), Quest Diagnostics (US), HYCOR Biomedical (US), Alletess Medical Laboratory (US), Kaleo Inc. (the US), Imutest Ltd (UK), Creative Diagnostics (US), Impax Laboratories (US), Mylan NV (US)

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    At what CAGR is the global egg allergy market projected to grow in the forecast period (2024-2032)?

    Egg allergy market projected to grow at approximately 6.90% CAGR during the assessment period (2022-2030).

    How much is the global egg allergy market worth in the future?

    The valuation of the global egg allergy market is estimated to increase to USD 2.016 Billion by the end of 2030

    What are the major tailwinds pushing the growth of the global egg allergy market?

    Increasing prevalence, improved allergy diagnosis, and rising healthcare expenses are major tailwinds pushing the growth of the global egg allergy market.

    Which region holds the largest share in the global egg allergy market?

    North America holds the largest share in the global egg allergy market, followed by Europe and the Asia Pacific, respectively.

    Who are the top players in the global egg allergy market?

    Genetech, Inc. (US), Mylan N.V. (US), Sanofi (France), Alletess Medical Laboratory (US), Creative Diagnostics (US), HYCOR Biomedical (US), Impax Laboratories, Inc. (US), Kaleo, Inc. (US), Kaleo, Inc. (US), Impax Laboratories (US), Quest Diagnostics (US), ImmuneTech (US), and Imutest Ltd. (UK), are some of the top players operating in the global egg allergy market.

    1. TABLE OF CONTENT    
    2. Chapter 1.    Report Prologue    
    3. Chapter 2.    Market Introduction    
      1.     Definition    
      2.     Scope of the Study    
        1.     Research Objective    
        2.     Assumptions    
        3.     Limitations    
    4. Chapter 3.    Research Methodology
      1.     Introduction
      2.     Primary Research    
      3.     Secondary research    
      4.     Market Size Estimation
    5. Chapter 4.    Market Dynamics
      1.     Drivers    
      2.     Restrains
      3.     Opportunities    
      4.     Challenges
      5.     Macroeconomic Indicators
      6.     Technology Trends & Assessment            
    6. Chapter 5.    Market Factor Analysis
      1.     Porter’s Five Forces Analysis
        1.     Bargaining Power of Suppliers    
        2.     Bargaining Power of Buyers
        3.     Threat of New Entrants    
        4.     Threat of Substitutes    
        5.     Intensity of Rivalry    
      2.     Value Chain Analysis
      3.     Investment Feasibility Analysis    
      4.     Pricing Analysis
    7. Chapter 6.    Global Encephalomyelitis Market, by Type
    8.          6.1    Introduction
      1.     Acute Disseminated Encephalomyelitis
    9. Market Estimates & Forecast, 2020 – 2027
      1.     Encephalomyelitis Disseminata
    10. Market Estimates & Forecast, 2020 – 2027
      1.     Deprivation & Occlusion Encephalomyelitis
    11. Market Estimates & Forecast, 2020 – 2027
      1.     AntiMOG Associated Encephalomyelitis
      2.     Equine Encephalomyelitis
    12. Market Estimates & Forecast, 2020 – 2027
      1.     AIDS Related Encephalomyelitis
    13.         6.8    Others
    14. Chapter 7.    Global Encephalomyelitis Market, by Treatment
    15.          7.1    Introduction
      1.     Drug Treatment
        1.     Antiviral Medications
        2.     Antibiotics
        3.     Steroids
        4.     Sedatives
        5.     NSAIDs
        6.     Mood Stabilizers
        7.     Others
      2.     Plasmapheresis
    16. Market Estimates & Forecast, 2020 – 2027
      1.     Surgery
    17. Market Estimates & Forecast, 2020 – 2027
      1.     Others
    18. Chapter 8.    Global Encephalomyelitis Market, by End User
      1.     Introduction
      2.     Hospitals
      3.     Clinics
      4.     Others
    19. Chapter 9.    Global Encephalomyelitis Market, by Region
      1.     Introduction
      2.     America
        1.     North America
        2.     South America
      3.     Europe
        1.     Western Europe
        2.     Eastern Europe
      4.     Asia Pacific
        1.     Japan
        2.     China
        3.     India
        4.     Australia
        5.     Republic of Korea
        6.     Rest of Asia Pacific
      5.     The Middle East & Africa
        1.     United Arab Emirates
        2.      Saudi Arabia
        3.     Oman
        4.     Kuwait
        5.     Qatar
        6.     Rest of the Middle East & Africa
    20. Chapter 10    Company Landscape    
      1.     Introduction    
      2.     Market Share Analysis    
      3.     Key Development & Strategies    
        1.     Key Developments    
    21. Chapter 11    Company Profiles    
      1.     Bristol-Myers Squibb Company     
        1.     Company Overview    
        2.     Product Overview    
        3.     Financials    
        4.     SWOT Analysis    
      2.     Sanofi     
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
        5.     SWOT Analysis    
      3.     GlaxoSmithKline Plc.    
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview
        4.     Key Development    
        5.     SWOT Analysis    
      4.     Amgen, Inc
        1.     Company Overview    
        2.     Product/Business Segment Overview    
        3.     Financial Overview    
        4.     Key Development    
        5.     SWOT Analysis    
      5.     Bayer AG
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial overview    
        4.     Key Developments    
      6.     Novartis AG     
        1.     Company Overview    
        2.     Product Overview    
        3.     Financial Overview    
        4.     Key Developments    
      7.     F. Hoffmann-La Roche Ltd
        1.     Overview    
        2.     Product Overview    
        3.     Financials    
        4.     Key Developments    
        5.     SWOT Analysis    
    22.     11.8    Others
    23. Chapter 12    MRFR Conclusion    
      1.     Key Findings    
        1.     From CEO’s View Point    
        2.     Unmet Needs of the Market    
      2.     Key Companies to Watch    
      3.     Prediction of Pharmaceutical Industry
    24. Chapter 13    Appendix
    25. DATA TABLES
    26. Table 1        Encephalomyelitis Industry Synopsis, 2020 – 2027
    27. Table 2        Global Encephalomyelitis Market Estimates and Forecast, 2020 – 2027, (USD Million)
    28. Table 3        Global Encephalomyelitis Market by Region, 2020 – 2027, (USD Million)
    29. Table 4        Global Encephalomyelitis Market by Types, 2020 – 2027, (USD Million)
    30. Table 5        Global Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    31. Table 6        Global Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    32. Table 7        North America Encephalomyelitis Market by Types, 2020 – 2027, (USD Million)
    33. Table 8        North America Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    34. Table 9        North America Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    35. Table 10    US Market by Types, 2020 – 2027, (USD Million)
    36. Table 11    US Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    37. Table 12    US Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    38. Table 13    Canada Market by Types, 2020 – 2027, (USD Million)
    39. Table 14    Canada Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    40. Table 15    Canada Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    41. Table 16    South America Market by Types, 2020 – 2027, (USD Million)
    42. Table 17    South America Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    43. Table 18    South America Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    44. Table 19    Europe Market by Types, 2020 – 2027, (USD Million)
    45. Table 20    Europe Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    46. Table 21    Europe Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    47. Table 22    Western Europe Market by Types, 2020 – 2027, (USD Million)
    48. Table 23    Western Europe Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    49. Table 24    Western Europe Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    50. Table 25    Eastern Europe Market by Types, 2020 – 2027, (USD Million)
    51. Table 26    Eastern Europe Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    52. Table 27    Eastern Europe Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    53. Table 28    Asia Pacific Market by Types, 2020 – 2027, (USD Million)
    54. Table 29    Asia Pacific Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    55. Table 30    Asia Pacific Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    56. Table 31    Middle East & Africa Market by Types, 2020 – 2027, (USD Million)
    57. Table 32    Middle East & Africa Encephalomyelitis Market by Treatment, 2020 – 2027, (USD Million)
    58. Table 33    Middle East & Africa Encephalomyelitis Market by End Users, 2020 – 2027, (USD Million)
    59. List of Tables and Figures
      1. LIST OF FIGURES
      2. Figure 1    Research Process
      3. Figure 2    Segmentation for Global Encephalomyelitis Market
      4. Figure 3    Segmentation Market Dynamics for Global Encephalomyelitis Market
      5. Figure 4    Global Encephalomyelitis market Share, by type 2020
      6. Figure 5    Global Encephalomyelitis market Share, by Treatment 2020
      7. Figure 6    Global Encephalomyelitis Market Share, by End Users, 2020
      8. Figure 7    Global Encephalomyelitis Market Share, by Region, 2020
      9. Figure 8    North America Encephalomyelitis Market Share, by Country, 2020
      10. Figure 9    Europe Encephalomyelitis Market Share, by Country, 2020
      11. Figure 10    Asia Pacific Encephalomyelitis Market Share, by Country, 2020
      12. Figure 11    Middle East & Africa Encephalomyelitis Market Share, by Country, 2020
      13. Figure 12    Global Encephalomyelitis Market: Company Share Analysis, 2020 (%)
      14. Figure 13    Bristol-Myers Squibb Company: Key Financials
      15. Figure 14    Bristol-Myers Squibb Company: Segmental Revenue
      16. Figure 15    Bristol-Myers Squibb Company: Geographical Revenue
      17. Figure 16    Sanofi: Key Financials
      18. Figure 17    Sanofi: Segmental Revenue
      19. Figure 18    Sanofi: Geographical Revenue
      20. Figure 19    GlaxoSmithKline Plc.: Key Financials
      21. Figure 20    GlaxoSmithKline Plc.: Segmental Revenue
      22. Figure 21    GlaxoSmithKline Plc.: Geographical Revenue
      23. Figure 22    Amgen, Inc: Key Financials
      24. Figure 23    Amgen, Inc: Segmental Revenue
      25. Figure 24    Amgen, Inc: Geographical Revenue
      26. Figure 25    Bayer AG: Key Financials
      27. Figure 26    Bayer AG: Segmental Revenue
      28. Figure 27    Bayer AG: Geographical Revenue
      29. Figure 28    Novartis AG : Key Financials
      30. Figure 29    Novartis AG : Segmental Revenue
      31. Figure 30    Novartis AG : Geographical Revenue
      32. Figure 31    F. Hoffmann-La Roche Ltd: Key Financials
      33. Figure 32    F. Hoffmann-La Roche Ltd: Segmental Revenue
      34. Figure 33    F. Hoffmann-La Roche Ltd: Geographical Revenue

    Egg Allergy Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials